MAM
CRSP icon

Morse Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,500
Closed -$243K 163
2021
Q2
$243K Buy
+1,500
New +$243K 0.06% 150